ENTRY       D00981                      Drug
NAME        Prednisolone sodium phosphate (JP18/USP);
            Pediapred (TN)
PRODUCT     ORAPRED (Concordia Pharmaceuticals)
            PEDIAPRED (Royal Pharmaceuticals)
            PREDNISOLONE SODIUM PHOSPHATE (Seton Pharmaceuticals)
  GENERIC   PREDNISOLONE SODIUM PHOSPHATE (A-S Medication Solutions)
            PREDNISOLONE SODIUM PHOSPHATE (Amneal Pharmaceuticals NY LLC)
            PREDNISOLONE SODIUM PHOSPHATE (Bausch & Lomb Incorporated)
            PREDNISOLONE SODIUM PHOSPHATE (Chartwell RX)
            PREDNISOLONE SODIUM PHOSPHATE (Edenbridge Pharmaceuticals LLC.)
            PREDNISOLONE SODIUM PHOSPHATE (PAI Holdings)
            PREDNISOLONE SODIUM PHOSPHATE (Pharmaceutical Associates)
            PREDNISOLONE SODIUM PHOSPHATE (Pharmaceutical Associates)
            PREDNISOLONE SODIUM PHOSPHATE (Pharmaceutical Associates)
            PREDNISOLONE SODIUM PHOSPHATE (Prasco Laboratories)
            PREDNISOLONE SODIUM PHOSPHATE (Preferred Pharmaceuticals)
            PREDNISOLONE SODIUM PHOSPHATE (Proficient Rx LP)
            PREDNISOLONE SODIUM PHOSPHATE (RedPharm Drug)
            PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION (BioComp Pharma)
FORMULA     C21H27O8P. 2Na
EXACT_MASS  484.1239
MOL_WEIGHT  484.3876
CLASS       Anti-inflammatory
             DG01955  Corticosteroid
              DG02068  Glucocorticoid
REMARK      Therapeutic category: 2456
            ATC code: A01AC04 A07EA01 C05AA04 D07AA03 D07XA02 H02AB06 R01AD02 S01BA04 S01CB02 S02BA03 S03BA02
            Chemical structure group: DG00093
            Product (DG00093): D00472<JP/US> D00980<JP/US> D00981<JP/US> D01239<JP> D03301<JP>
            Product (mixture): D11699<US>
EFFICACY    Anti-inflammatory, Glucocorticoid receptor agonist
  DISEASE   Atopic dermatitis [DS:H01358]
            Allergic rhinitis [DS:H01360]
            Bullous dermatitis herpetiformis [DS:H01362]
            Contact dermatitis [DS:H01357]
            Mycosis fungoides [DS:H01463]
            Pemphigus [DS:H01648]
            Severe erythema multiforme [DS:H01695]
            Stevens-Johnson syndrome [DS:H01694]
            Congenital adrenal hyperplasia [DS:H00216]
            Primary or secondary adrenocortical insufficiency [DS:H01598]
            Crohn's disease [DS:H00286]
            Ulcerative colitis [DS:H01466]
            Acquired (autoimmune) hemolytic anemia [DS:H01585]
            Diamond-Blackfan anemia [DS:H00237]
            Pure red cell aplasia [DS:H01586]
            Multiple sclerosis [DS:H01490]
            Acute or chronic solid organ rejection [DS:H00083]
            Chronic obstructive pulmonary disease [DS:H01714]
            Allergic bronchopulmonary aspergillosis [DS:H01328]
            Asthma [DS:H00079]
            Pulmonary tuberculosis [DS:H00342]
            Hypersensitivity pneumonitis [DS:H00346]
            Idiopathic bronchiolitis obliterans [DS:H01873]
            Idiopathic pulmonary fibrosis [DS:H01299]
            Pneumocystis carinii pneumonia [DS:H01521]
            Nephrotic syndrome [DS:H01657]
            Ankylosing spondylitis [DS:H01674]
            Dermatomyositis and polymyositis [DS:H01604]
            Polymyalgia rheumatica [DS:H01606]
            Temporal arteritis [DS:H01698]
            Psoriatic arthritis [DS:H01507]
            Relapsing polychondritis [DS:H01758]
            Rheumatoid arthritis [DS:H00630]
            Juvenile rheumatoid arthritis [DS:H01672]
            Sjogren's Syndrome [DS:H01502]
            Systemic lupus erythematosus [DS:H00080]
            Trichinosis with neurologic or myocardial involvement [DS:H01099]
TARGET      NR3C1 (GR) [HSA:2908] [KO:K05771]
  PATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07225  Glucocorticoid and mineralocorticoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AC Corticosteroids for local oral treatment
                 A01AC04 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
              A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
               A07E INTESTINAL ANTIINFLAMMATORY AGENTS
                A07EA Corticosteroids acting locally
                 A07EA01 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
             C CARDIOVASCULAR SYSTEM
              C05 VASOPROTECTIVES
               C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
                C05AA Corticosteroids
                 C05AA04 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
             D DERMATOLOGICALS
              D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
               D07A CORTICOSTEROIDS, PLAIN
                D07AA Corticosteroids, weak (group I)
                 D07AA03 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
               D07X CORTICOSTEROIDS, OTHER COMBINATIONS
                D07XA Corticosteroids, weak, other combinations
                 D07XA02 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H02 CORTICOSTEROIDS FOR SYSTEMIC USE
               H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
                H02AB Glucocorticoids
                 H02AB06 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
             R RESPIRATORY SYSTEM
              R01 NASAL PREPARATIONS
               R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
                R01AD Corticosteroids
                 R01AD02 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01B ANTIINFLAMMATORY AGENTS
                S01BA Corticosteroids, plain
                 S01BA04 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
               S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
                S01CB Corticosteroids/antiinfectives/mydriatics in combination
                 S01CB02 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
              S02 OTOLOGICALS
               S02B CORTICOSTEROIDS
                S02BA Corticosteroids
                 S02BA03 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
              S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
               S03B CORTICOSTEROIDS
                S03BA Corticosteroids
                 S03BA02 Prednisolone
                  D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
              Prednisolone
               D00981  Prednisolone sodium phosphate (JP18/USP)
             Inflammatory Bowel Disease Agents
              Glucocorticoids
               Prednisolone
                D00981  Prednisolone sodium phosphate (JP18/USP)
             Ophthalmic Agents
              Ophthalmic Anti-inflammatories
               Glucocorticoids, Ophthalmic
                Prednisolone
                 D00981  Prednisolone sodium phosphate (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               245  Adrenal hormone preparations
                2456  Prednisolones
                 D00981  Prednisolone sodium phosphate (JP18/USP)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00093  Prednisolone
                 D00981  Prednisolone sodium phosphate
            Drug classes [BR:br08332]
             Anti-inflammatory
              DG01955  Corticosteroid
               D00981  Prednisolone sodium phosphate
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                NR3C1 (GR)
                 D00981  Prednisolone sodium phosphate (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00981  Prednisolone sodium phosphate
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00093  Prednisolone
DBLINKS     CAS: 125-02-0
            PubChem: 7848044
            ChEBI: 8379
            LigandBox: D00981
            NIKKAJI: J5.364C
ATOM        32
            1   C2x C     3.4829  -12.1384
            2   C5x C     3.4829  -13.5014
            3   C2x C     4.6633  -14.1829
            4   C2y C     5.8437  -13.5014
            5   C1z C     5.8437  -12.1384
            6   C2x C     4.6633  -11.4568
            7   C1x C     7.0241  -14.1829
            8   C1x C     8.2045  -13.5014
            9   C1y C     8.2045  -12.1384
            10  C1y C     7.0241  -11.4568
            11  C1y C     9.3850  -11.4568
            12  C1z C     9.3850  -10.0938
            13  C1x C     8.2045   -9.4123
            14  C1y C     7.0241  -10.0938
            15  C1x C    11.7457  -11.4568
            16  C1x C    11.7457  -10.0938
            17  C1z C    10.5654   -9.4123
            18  O5x O     2.3025  -14.1829
            19  C1a C     5.8437  -10.7753
            20  O1a O     5.8457   -9.4135
            21  C1a C     9.3850   -8.7308
            22  C5a C    10.5654   -7.6348
            23  O1a O    11.7457   -8.7308
            24  C1b C    11.7497   -6.9511
            25  O5a O     9.3889   -6.9555
            26  O2b O    12.9156   -7.6243
            27  P1b P    14.1511   -6.9106
            28  O1c O    15.3635   -6.2106 #-
            29  O1c O    13.4565   -5.7082 #-
            30  O1c O    14.8569   -8.1325
            31  Z   Na   11.1300   -5.6700 #+
            32  Z   Na   17.5700   -6.0200 #+
BOND        33
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 1
            20   12  17 1
            21    2  18 2
            22    5  19 1 #Up
            23   14  20 1 #Up
            24   12  21 1 #Up
            25   17  22 1 #Up
            26   17  23 1 #Down
            27   22  24 1
            28   22  25 2
            29   24  26 1
            30   26  27 1
            31   27  28 1
            32   27  29 1
            33   27  30 2
///
